BEN Reports Third Quarter 2024 Financial Results
"In the third quarter, we made significant progress in delivering secure, scalable AI solutions and advancing our mission to transform industries with intelligent technology," said
Q3 2024 Key Business Highlights:
KangarooHealth Partnership : BEN partnered with KangarooHealth to enhance remote patient monitoring and chronic care management through AI, aiming to scale their platform for patients with chronic conditions.- IntelliTek Collaboration: BEN’s agreement with IntelliTek broadens global access to AI solutions for healthcare, supporting patient engagement and optimizing healthcare operations across multiple regions.
- INTERVENT & Members Only Health Contracts: BEN signed with
INTERVENT and Members Only Health to deploy AI assistants for health coaching and in-home healthcare, enhancing patient engagement and access. Vybroo & Farmacia Roma Partnership : BEN collaborated with Vybroo and Farmacia Roma to offer AI-driven audio engagement, enhancing brand-consumer relationships through accessible, everyday channels.- New SEPA Agreement: BEN entered into a
$50 million Standby Equity Purchase Agreement (SEPA) withYorkville Advisors , providing financial flexibility. - Leadership Promotion:
Paul Chang was promoted to CEO, reinforcing BEN’s commitment to strategic growth and customer-focused initiatives. - New Board Member: Dr.
Richard S. Isaacs , former CEO ofKaiser Permanente , was appointed to BEN's board of directors, bringing healthcare technology innovation and leadership expertise.
Q3 2024 Financial Overview:
- Revenue Growth: Achieved increase in revenue compared to the same period last year, driven by new partnerships and market expansion.
- Operational Efficiency: Improved operational metrics through continued cost discipline, resulting in a sequential reduction in operating costs and quarter-over-quarter operating loss improvement, coupled with strategic collaborations and technology advancements.
- Cash Position: Quarter over-quarter sequential improvement in Cash Flow from Operations driven by disciplined cost management. Implementing the Standby Equity Purchase Agreement (SEPA) provided cost-effective and efficient access to capital and liquidity.
- Significant subsequent event: In October, the Company announced its agreement to acquire 100% of
Cantaneo Gmbh , a leading media technology company based inGermany , for$19.5 million in cash and stock. BEN expects to close this transaction by the end of the year.
Conference Call and Webcast Information
The Company will host a conference call and webcast today,
Participants can register here to access the live webcast of the conference call. Those who prefer to join the call via phone can register using this link to receive a dial-in number and unique PIN.
The webcast will be archived for one year following the conference call and can be accessed on BEN’s investor relations website at https://investors.beninc.ai/.
For more information about BEN’s safe, intelligent, scalable AI, please visit www.beninc.ai.
About BEN
Brand Engagement Network Inc. is a global leader in providing secure and reliable conversational AI solutions for businesses and consumers. With offices in Jackson,
Forward-Looking Statements
This communication contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are not historical facts, and involve risks and uncertainties that could cause actual results of BEN to differ materially from those expected and projected. These forward-looking statements can be identified by the use of forward-looking terminology, including the words “anticipates,” “believes,” “continue,” “estimates,” “expects,” “intends,” “may,” “plans,” “potential,” “predicts,” “projects,” “should,” “will,” or “would,” or, in each case, their negative or other variations or comparable terminology.
These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside BEN’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: uncertainties as to the timing of the acquisition with
BEN cautions that the foregoing list of factors is not exclusive. BEN cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. BEN does not undertake nor does it accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, and it does not intend to do so unless required by applicable law. Further information about factors that could materially affect BEN, including its results of operations and financial condition, is set forth under “Risk Factors” in BEN’s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q subsequently filed with the
BEN Contacts:
Investor Relations
E: sxu@allianceadvisors.com
P: 778-323-0959
Media Contact
E: amy@beninc.ai
P: 503-367-7596
Source: Brand Engagement Network, Inc. (BEN)
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||
2024 |
2023* |
||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 72,878 | $ | 1,685,013 | |||
Accounts receivable, net of allowance | 30,888 | 10,000 | |||||
Due from Sponsor | 3,000 | — | |||||
Prepaid expenses and other current assets | 1,075,103 | 201,293 | |||||
Total current assets | 1,181,869 | 1,896,306 | |||||
Property and equipment, net | 285,305 | 802,557 | |||||
Intangible assets, net | 17,006,906 | 17,882,147 | |||||
Other assets | 13,475,000 | 1,427,729 | |||||
TOTAL ASSETS | $ | 31,949,080 | $ | 22,008,739 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 5,376,310 | $ | 1,282,974 | |||
Accrued expenses | 4,185,315 | 1,637,048 | |||||
Due to related parties | 693,036 | — | |||||
Deferred revenue | — | 2,290 | |||||
Convertible note | 1,900,000 | — | |||||
Short-term debt | 891,974 | 223,300 | |||||
Total current liabilities | 13,046,635 | 3,145,612 | |||||
Warrant liabilities | 1,150,868 | — | |||||
Note payable - related party | — | 500,000 | |||||
Long-term debt | — | 668,674 | |||||
Total liabilities | 14,197,503 | 4,314,286 | |||||
Commitments and contingencies (Note M) | |||||||
Stockholders’ equity: | |||||||
Preferred stock par value |
— | — | |||||
Common stock par value of |
3,794 | 2,327 | |||||
Additional paid-in capital | 46,806,699 | 30,993,846 | |||||
Accumulated deficit | (29,058,916 | ) | (13,301,720 | ) | |||
Total stockholders’ equity | 17,751,577 | 17,694,453 | |||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 31,949,080 | $ | 22,008,739 | |||
* Derived from audited information | |||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||
Revenues | $ | 50,000 | $ | — | $ | 99,790 | $ | — | |||||||
Cost of revenues | — | — | — | — | |||||||||||
Gross profit | 50,000 | — | 99,790 | — | |||||||||||
Operating expenses: | |||||||||||||||
General and administrative | 4,203,946 | 2,282,434 | 15,969,617 | 7,678,880 | |||||||||||
Depreciation and amortization | 972,375 | 209,729 | 1,771,966 | 449,663 | |||||||||||
Research and development | 153,191 | 75,450 | 759,427 | 153,828 | |||||||||||
Total operating expenses | 5,329,512 | 2,567,613 | 18,501,010 | 8,282,371 | |||||||||||
Loss from operations | (5,279,512 | ) | (2,567,613 | ) | (18,401,220 | ) | (8,282,371 | ) | |||||||
Other income (expenses): | |||||||||||||||
Interest expense | (18,055 | ) | (34,507 | ) | (62,508 | ) | (34,507 | ) | |||||||
Interest income | 92 | — | 3,324 | — | |||||||||||
Gain on debt extinguishment | 98,318 | — | 1,946,310 | — | |||||||||||
Change in fair value of warrant liabilities | (632,969 | ) | — | 762,869 | — | ||||||||||
Other | 9,043 | 19,789 | (5,971 | ) | (11,961 | ) | |||||||||
Other income (expenses), net | (543,571 | ) | (14,718 | ) | 2,644,024 | (46,468 | ) | ||||||||
Loss before income taxes | (5,823,083 | ) | (2,582,331 | ) | (15,757,196 | ) | (8,328,839 | ) | |||||||
Income taxes | — | — | — | — | |||||||||||
Net loss | $ | (5,823,083 | ) | $ | (2,582,331 | ) | $ | (15,757,196 | ) | $ | (8,328,839 | ) | |||
Net loss per common share- basic and diluted | $ | (0.16 | ) | $ | (0.12 | ) | $ | (0.50 | ) | $ | (0.42 | ) | |||
Weighted-average common shares - basic and diluted | 35,539,043 | 22,409,790 | 31,623,082 | 19,928,947 | |||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) |
|||||||||||||||||||||
Preferred Stock | Common Stock | Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Equity |
|||||||||||||||||
Shares | Par Value | Shares | Par Value | ||||||||||||||||||
Balance at |
— | $ | — | 23,270,404 | $ | 2,327 | $ | 30,993,846 | $ | (13,301,720 | ) | $ | 17,694,453 | ||||||||
Stock issued to DHC shareholders in reverse recapitalization | — | — | 7,885,220 | 789 | (10,722,277 | ) | — | (10,721,488 | ) | ||||||||||||
Issuance of common stock pursuant to Reseller Agreement | — | — | 1,750,000 | 175 | 13,474,825 | — | 13,475,000 | ||||||||||||||
Sale of common stock | — | — | 645,917 | 65 | 6,324,935 | — | 6,325,000 | ||||||||||||||
Warrant exercises | — | — | 40,514 | 4 | 15,260 | — | 15,264 | ||||||||||||||
Stock-based compensation | — | — | — | — | 698,705 | — | 698,705 | ||||||||||||||
Net loss | — | — | — | — | — | (6,884,409 | ) | (6,884,409 | ) | ||||||||||||
Balance at |
— | — | 33,592,055 | 3,360 | 40,785,294 | (20,186,129 | ) | 20,602,525 | |||||||||||||
Stock issued in settlement of accounts payable and loans payable | — | — | 93,333 | 9 | 321,999 | — | 322,008 | ||||||||||||||
Sale of common stock | — | — | 877,500 | 198 | 1,993,552 | — | 1,993,750 | ||||||||||||||
Warrant exercises | — | — | 13,505 | 1 | 4,999 | — | 5,000 | ||||||||||||||
Stock-based compensation, including vested restricted shares | — | — | 381,915 | 42 | 768,497 | — | 768,539 | ||||||||||||||
Net loss | — | — | — | — | — | (3,049,704 | ) | (3,049,704 | ) | ||||||||||||
Balance at |
— | — | 34,958,308 | 3,610 | 43,874,341 | (23,235,833 | ) | 20,642,118 | |||||||||||||
Issuance of common stock for Standby Equity Purchase Agreement commitment fee | — | — | 280,899 | 28 | 499,972 | — | 500,000 | ||||||||||||||
Stock issued in settlement of accrued expenses | — | — | 151,261 | 15 | 261,667 | — | 261,682 | ||||||||||||||
Sale of common stock | — | — | 602,500 | 131 | 1,756,056 | — | 1,756,187 | ||||||||||||||
Option and warrant exercises | — | — | 98,335 | 10 | 79,750 | — | 79,760 | ||||||||||||||
Stock-based compensation, including vested restricted shares | — | — | 35,461 | — | 334,913 | — | 334,913 | ||||||||||||||
Net loss | — | — | — | — | — | (5,823,083 | ) | (5,823,083 | ) | ||||||||||||
Balance at |
— | $ | — | 36,126,764 | $ | 3,794 | $ | 46,806,699 | $ | (29,058,916 | ) | $ | 17,751,577 |
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) |
||||||||||||||||||||
Preferred Stock | Common Stock | Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Deficit |
||||||||||||||||
Shares | Par Value | Shares | Par Value | |||||||||||||||||
Balance at |
— | $ | — | 17,057,085 | $ | 1,705 | $ | 1,528,642 | $ | (1,570,454 | ) | $ | (40,107 | ) | ||||||
Warrant exercises | — | — | 81,030 | 8 | 29,992 | — | 30,000 | |||||||||||||
Stock issued in conversion of accounts payable and loans payable | — | — | 135,050 | 14 | 49,986 | — | 50,000 | |||||||||||||
Stock-based compensation | — | — | — | — | 2,442,701 | — | 2,442,701 | |||||||||||||
Net loss | — | — | — | — | — | (2,637,956 | ) | (2,637,956 | ) | |||||||||||
Balance at |
— | — | 17,273,165 | 1,727 | 4,051,321 | (4,208,410 | ) | (155,362 | ) | |||||||||||
Stock issued for DM Lab APA | — | — | 4,325,043 | 433 | 16,012,317 | — | 16,012,750 | |||||||||||||
Options and warrant exercises | — | — | 56,552 | 10 | 20,928 | — | 20,938 | |||||||||||||
Stock issued in conversion of convertible notes | — | — | 378,140 | 38 | 1,399,962 | — | 1,400,000 | |||||||||||||
Stock issued in settlement of accounts payable and loans payable | — | — | 103,439 | 10 | 382,953 | — | 382,963 | |||||||||||||
Stock-based compensation | — | — | — | — | 1,841,767 | — | 1,841,767 | |||||||||||||
Net loss | — | — | — | — | — | (3,108,552 | ) | (3,108,552 | ) | |||||||||||
Balance at |
— | — | 22,136,339 | 2,218 | 23,709,248 | (7,316,962 | ) | 16,394,504 | ||||||||||||
Options and warrant exercises | — | — | 64,993 | 3 | 9,997 | — | 10,000 | |||||||||||||
Vesting of early exercised options | — | — | — | — | 1,563 | — | 1,563 | |||||||||||||
Stock issued in conversion of convertible notes | — | — | 432,160 | 43 | 1,599,957 | — | 1,600,000 | |||||||||||||
Sale of common stock, net of issuance costs | — | — | 123,333 | 12 | 949,988 | — | 950,000 | |||||||||||||
Stock-based compensation | — | — | — | — | 464,075 | — | 464,075 | |||||||||||||
Net loss | — | — | — | — | — | (2,582,331 | ) | (2,582,331 | ) | |||||||||||
Balance at |
— | $ | — | 22,756,825 | $ | 2,276 | $ | 26,734,828 | $ | (9,899,293 | ) | $ | 16,837,811 | |||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS |
|||||||
Nine Months Ended |
|||||||
2024 | 2023 | ||||||
Cash flows from operating activities: | |||||||
Net loss | $ | (15,757,196 | ) | $ | (8,328,839 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||
Depreciation and amortization expense | 1,771,966 | 449,663 | |||||
Allowance for uncollected receivables | 30,000 | — | |||||
Write off of deferred financing fees | 1,427,729 | — | |||||
Change in fair value of warrant liabilities | (762,869 | ) | — | ||||
Gain on debt extinguishment | (1,946,310 | ) | — | ||||
SEPA financing costs | 525,000 | — | |||||
Stock based compensation, including the issuance of restricted shares | 1,581,744 | 4,727,799 | |||||
Changes in operating assets and liabilities: | |||||||
Prepaid expense and other current assets | (856,986 | ) | (103,917 | ) | |||
Accounts receivable | (50,888 | ) | 500 | ||||
Accounts payable | 5,393,334 | 62,373 | |||||
Accrued expenses | (3,019,367 | ) | 431,194 | ||||
Other assets | — | 8,850 | |||||
Deferred revenue | (2,290 | ) | — | ||||
Net cash used in operating activities | (11,666,133 | ) | (2,752,377 | ) | |||
Cash flows from investing activities: | |||||||
Purchase of property and equipment | (53,023 | ) | (28,465 | ) | |||
Purchase of patents | — | (379,864 | ) | ||||
Capitalized internal-use software costs | (162,940 | ) | (310,944 | ) | |||
Asset acquisition (Note D) | — | (257,113 | ) | ||||
Net cash used in investing activities | (215,963 | ) | (976,386 | ) | |||
Cash flows from financing activities: | |||||||
Cash and cash equivalents acquired in connection with the reverse recapitalization | 858,292 | — | |||||
Proceeds from the sale of common stock | 10,274,937 | 1,000,000 | |||||
Proceeds from convertible notes | — | 3,075,000 | |||||
Proceeds from related party note | — | 620,000 | |||||
Proceeds received from option and warrant exercises | 100,024 | 22,500 | |||||
Payment of financing costs | (883,292 | ) | (107,310 | ) | |||
Payment of related party note | (80,000 | ) | — | ||||
Advances to related parties | — | (39,065 | ) | ||||
Proceeds received from related party advance repayments | — | 138,110 | |||||
Net cash provided by financing activities | 10,269,961 | 4,709,235 | |||||
Net (decrease) increase in cash and cash equivalents | (1,612,135 | ) | 980,472 | ||||
Cash and cash equivalents at the beginning of the period | 1,685,013 | 2,010 | |||||
Cash and cash equivalents at the end of the period | $ | 72,878 | $ | 982,482 | |||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS |
|||||
Nine Months Ended |
|||||
2024 | 2023 | ||||
Supplemental Cash Flow Information | |||||
Cash paid for interest | $ | — | $ | — | |
Cash paid for income taxes | $ | — | $ | — | |
Supplemental Non-Cash Information | |||||
Capitalized internal-use software costs in accrued expenses | $ | — | $ | 46,963 | |
Issuance of common stock pursuant to Reseller Agreement | $ | 13,475,000 | $ | — | |
Issuance of common stock for Standby Equity Purchase Agreement commitment fee | $ | 500,000 | $ | — | |
Stock-based compensation capitalized as part of capitalized software costs | $ | 220,413 | $ | 20,745 | |
Settlement of liabilities into common shares | $ | 583,690 | $ | 432,963 | |
Settlement of accounts payable into convertible note | $ | 1,900,000 | $ | — | |
Conversion of convertible notes into common shares | $ | — | $ | 3,000,000 | |
Warrants exercise through settlement of accounts payable | $ | — | $ | 40,000 | |
Financing costs in accounts payable and accrued expenses | $ | 200,000 | $ | 687,609 | |
Issuance of common stock in connection with asset acquisition | $ | — | $ | 16,012,750 | |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
Source: Brand Engagement Network, Inc.